七月 2026
- Home
- NEUROPHET
七月 2026的NEUROPHET市场份额分析
Founded in 2016, Neurophet is a specialized company dedicated to researching and developing AI technology-based brain imaging analysis solutions and therapeutic medical devices across the entire cycle of "diagnosis, treatment guidance, and treatment." Under the mission of The Pioneer of Brain Frontiers, Neurophet continues its journey to become a global Pioneer in AI-Driven Diagnosis and Treatment of Brain Disorders.
NEUROPHET(包含公司地区分支机构)
查看更多网站流量和参与度信息- neurophet.com
NEUROPHET热门域名的总访问量
了解NEUROPHET市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
NEUROPHET热门域名的平均访问时长
分析NEUROPHET参与度指标。
过去 3 个月的平均访问时长
子公司明细
NEUROPHET热门域名的平均页面浏览量
了解NEUROPHET如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
NEUROPHET 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Neurophet signed new client Raffles Medical Group on Jul 14th '26.* Raffles Medical has signed Neurophet to supply AQUA, an AI-powered neurodegenerative brain-imaging analysis software, for its network of private hospitals.
七月 14, 2026阅读更多
新闻NEUROPHET, Inc. is developing AI algorithms on Jun 23rd '26.Based on these datasets, Neurophet will develop and validate AI algorithms.
六月 23, 2026阅读更多
新闻NEUROPHET, Inc. attended event BIO USA on Jun 22nd '26.Neurophet showcases 'brain imaging AI solutions' at BIO USA, accelerates global business development collaborations.
六月 16, 2026阅读更多
查看 NEUROPHET 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。
